Press & events

What's happening?

Stay updated on our latest news and events.

Displaying 1 - 10 of 190

Insights

The rapid growth in biopharmaceuticals, an increasingly complex drug landscape, and the rising expectations from consumers around administration convenience, are all contributing factors driving demand for new delivery solutions across the pharma industry.

Insights

The pharma industry has faced unprecedented challenges since the outbreak of COVID-19. 2021 has the potential to provide a platform for change, as work and everyday life continues to be transformed as a result of the global pandemic and other key events in 2020.

Insights

Throughout the course of COVID-19, the market demand for fixed dose combinations (FDCs) used in treatment of fever and common colds has risen significantly. In response to this demand, a number of Recipharm’s customers have had to update their analytical methodologies to ensure they are workable throughout the lifecycle of the drug product.

Insights

The COVID-19 pandemic has impacted pharma in ways like never before. Not only is the industry at the forefront of the efforts to combat the virus, but it is subject to immense vulnerability, with the various lockdowns putting unprecedented pressure on operations and exposing the weakness of the world’s API supply chain.

Insights

Innovative thinking can offer many benefits when it comes to analytical chemistry. For example, reduced timelines in the delivery vital medicines to patients and improved efficiencies. With drug developers shifting their focus to concentrate on core capabilities and redirecting resources, the outsourcing market for analytical services is growing rapidly.

Insights

Demand for inhalation products with multiple APIs has surged in recent years as companies rise to the challenge of meeting the needs of respiratory patients worldwide.

To develop a successful combination drug product, it is crucial to choose the right manufacturing technique, which will depend on the dosage form you choose.

Insights

Different dosage forms have a varying impact on patient compliance and their ability to take medications effectively. Many patients struggle to consume standard tablet dosage forms due to various health problems, including dysphagia (a swallowing disorder) and Parkinson’s disease.

Insights

While oral solid dose (OSD) products may seem obsolete compared with the new generation of biopharmaceutical products, they remain extremely popular. 

The challenge for OSD products moving forward will be to maintain their advantage as other dosage forms such as parenteral products.

Insights

Europe’s reliance on active pharmaceutical ingredients (APIs) which are not manufactured domestically is now under the spotlight more than ever. Recent world events have led to several governments trying to influence companies to relocate their API and pharmaceutical production back to Europe, if not their home country.  

Insights

Asthma and chronic obstructive pulmonary disease (COPD) are some of the greatest challenges facing global health services, requiring a new generation of more effective treatments.